Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nicole Phan"'
Autor:
Aaron N. Hata, Paul E. Hughes, Cyril H. Benes, Angela Coxon, Sean P. Brown, Kristopher A. Sarosiek, Justin F. Gainor, Christopher G. Azzoli, Anna F. Farago, Zofia Piotrowska, Lecia V. Sequist, Colleen Keyes, John H. Shin, Daniel P. Cahill, Kevin A. Raskin, Cameron D. Wright, Michael Lanuti, Lorin A. Ferris, Kristof Vajda, Diamanda Rigas, Cameron Fraser, Chendi Li, Hannah L. Archibald, Maria Gomez-Caraballo, Nicole Phan, Samantha J. Bilton, Daria Timonina, Sean Caenepeel, Faria M. Siddiqui, Varuna Nangia
BH3 mimetic drugs, which inhibit prosurvival BCL2 family proteins, have limited single-agent activity in solid tumor models. The potential of BH3 mimetics for these cancers may depend on their ability to potentiate the apoptotic response to chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70abe6bdd9a6b3e57487dfcfd1b546b5
https://doi.org/10.1158/2159-8290.c.6547298.v1
https://doi.org/10.1158/2159-8290.c.6547298.v1
Autor:
Aaron N. Hata, Paul E. Hughes, Cyril H. Benes, Angela Coxon, Sean P. Brown, Kristopher A. Sarosiek, Justin F. Gainor, Christopher G. Azzoli, Anna F. Farago, Zofia Piotrowska, Lecia V. Sequist, Colleen Keyes, John H. Shin, Daniel P. Cahill, Kevin A. Raskin, Cameron D. Wright, Michael Lanuti, Lorin A. Ferris, Kristof Vajda, Diamanda Rigas, Cameron Fraser, Chendi Li, Hannah L. Archibald, Maria Gomez-Caraballo, Nicole Phan, Samantha J. Bilton, Daria Timonina, Sean Caenepeel, Faria M. Siddiqui, Varuna Nangia
Supplementary Figure 1-5, Supplementary Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d14dcf58051aa128a6d420a7ae16b05
https://doi.org/10.1158/2159-8290.22533896.v1
https://doi.org/10.1158/2159-8290.22533896.v1
Autor:
Kyle Vaccaro, Juliet Allen, Troy W. Whitfield, Asaf Maoz, Sarah Reeves, José Velarde, Dian Yang, Nicole Phan, George W. Bell, Aaron N. Hata, Kipp Weiskopf
Macrophage immune checkpoint inhibitors, such as anti-CD47 antibodies, show promise in clinical trials for solid and hematologic malignancies. However, the best strategies to use these therapies remain unknown and ongoing studies suggest they may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddb0b5dc241ecb4be55bfd6edb97590e
https://doi.org/10.1101/2023.03.03.531059
https://doi.org/10.1101/2023.03.03.531059
Autor:
Larisa Shagabayeva, Christopher R. Morse, Cameron E. Comrie, Felix G. Fernandez, Nikhil Panda, Chi-Fu Jeffrey Yang, Philicia Moonsamy, Nicole Phan
Publikováno v:
The Annals of Thoracic Surgery. 113:264-270
In this era of value-based healthcare, costs must be measured alongside patient outcomes to prioritize quality improvement and inform performance-based reimbursement strategies. We sought to identify drivers of costs for patients undergoing minimally
Autor:
Lorin A. Ferris, Kristof Vajda, Hannah L. Archibald, Daniel P. Cahill, Justin F. Gainor, Diamanda Rigas, Sean P. Brown, Anna F. Farago, Aaron N. Hata, Chendi Li, Cyril H. Benes, Kevin A. Raskin, Varuna Nangia, Michael Lanuti, Cameron D. Wright, John H. Shin, Kristopher A. Sarosiek, Lecia V. Sequist, Christopher G. Azzoli, Angela Coxon, Daria Timonina, Faria M. Siddiqui, Zofia Piotrowska, Paul E. Hughes, Sean Caenepeel, Cameron Fraser, Maria Gomez-Caraballo, Nicole Phan, Colleen Keyes, Samantha J. Bilton
Publikováno v:
Cancer Discovery. 8:1598-1613
BH3 mimetic drugs, which inhibit prosurvival BCL2 family proteins, have limited single-agent activity in solid tumor models. The potential of BH3 mimetics for these cancers may depend on their ability to potentiate the apoptotic response to chemother
Autor:
Mandeep Banwait, Pégah Jalili, Jiachen Lin, Heidie Frisco-Cabanos, S. Oh, Nicole Phan, Lee Zou, Zofia Piotrowska, Marcello Stanzione, Daria Timonina, L.V. Sequist, Jeffrey A. Engelman, Varuna Nangia, Rémi Buisson, Faria M. Siddiqui, Rosemary Cobb, Aaron N. Hata, K. Dionne, Jaewon J. Lee, Hannah L. Archibald, Cyril H. Benes, Amanda K. Riley, Nicholas J. Dyson, Michael W. Lawlor, Cheong Xin Chan, Christopher J. Ott, H. Isozaki, A. Abbasi, Maria Gomez-Caraballo, Gad Getz, Adam Langenbucher, Samantha J. Bilton, Alice T. Shaw, Yosef E. Maruvka, Wenjia Su, Michael S. Lawrence, N. Nikpour
Acquired drug resistance to even the most effective anti-cancer targeted therapies remains an unsolved clinical problem. Although many drivers of acquired drug resistance have been identified1‒6, the underlying molecular mechanisms shaping tumor ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::152a1f612e569ef1a840877cfed64792
https://doi.org/10.1101/2021.01.20.426852
https://doi.org/10.1101/2021.01.20.426852
Autor:
Barry Zuckerman, Megan H. Bair-Merritt, Jane G. Stapleton, Avanti Adhia, Nicole Phan, Sharyn J. Potter
Publikováno v:
Journal of Aggression, Maltreatment & Trauma. 26:276-296
Community-level bystander approaches with media campaigns have successfully reduced sexual violence, but these programs have not been developed for child maltreatment prevention. This study informs...